INS and type 2 diabetes mellitus: As impaired insulin secretion is a confounding factor in the appearance of type 2 diabetes, a chronic multifactorial disease with increased risk of vascular complications affecting millions of patients worldwide [93], food-derived bioactive peptides represent a promising adjuvant strategy in the context of disease management.